🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
24-week, randomized, double blind, placebo-controlled trial to evaluate saf...
Status
Unknown
Location
Atlanta VA Medical Center
Start Date
2016-01
Trial ID
NCT02624908
Treatments Being Tested
The purpose of this study is to evaluate the bioequivalence of metformin co...
Status
Completed
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02221180
BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Status
Completed
Location
Unit of Endocrinology and Metabolic Diseases
Start Date
2019-11-27
Trial ID
NCT04196231
Treatments Being Tested
The purpose of this study is to evaluate the bioequivalence of fixed dose c...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01454622
The purpose of this study is to assess the effect of canagliflozin (JNJ-284...
Status
Completed
Location
Multiple Locations
Start Date
2014-02
Trial ID
NCT02025907
Treatments Being Tested
The purpose of this study is to evaluate the effect of dose on the pharmaco...
Status
Completed
Location
Multiple Locations
Start Date
2011-05
Trial ID
NCT01340677
Treatments Being Tested
Obesity is closely associated with an increased risk of cardiomyopathy beca...
Status
Completed
Location
National Cheng Kung University Hospital
Start Date
2020-03-06
Trial ID
NCT05764811
Treatments Being Tested
The purpose of this study is to assess the effect of canagliflozin (JNJ-284...
Status
Completed
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT01787357
Treatments Being Tested
The study will assess canagliflozin (JNJ-28431754) in the treatment of pati...
Status
Completed
Location
Multiple Locations
Start Date
2009-12-09
Trial ID
NCT01032629
Treatments Being Tested
Diabetic kidney disease has become the leading cause for ESRD worldwide.Alb...
Status
Unknown
Location
Zhongshan Hospital Xiamen University
Start Date
2019-10-15
Trial ID
NCT04127084
Treatments Being Tested